Новости и события InnPharma: актуальные мероприятия и конференции
Revolutionizing Pharma Manufacturing with Biofermentation
Synthetic Chemistry and Integrated Biofermentation Transformational Pharmaceutical Manufacturing Combining biofermentation with chemical synthesis is shown to be creative in the
Asia-Pacific Governments Boost Healthcare Innovation And R&D
Several Asian-Pacific local governments have passed helpful policies and rules in the last five years to improve healthcare and speed
Biotech Outsourcing: Trends, CDMO Growth, And Expansion
Outsourcing has become an important part of the biotech business because many contract manufacturing organizations (CMOs) are the only ones
Advancing Continuous Bioprocessing For Enhanced Productivity
The biopharmaceutical sector is now going through a significant transition toward continuous bioprocessing which is currently taking place. In contrast
Generative AI In Pharma: Major Opportunities And Hurdles
Among the pharmaceutical DX-digital transformation professionals, 67% responded that they were not ready when asked about how ready the life
Global Biopharma Market To Hit $566B By 2032 Amid Challenges
The value of the global biopharmaceutical industry is expected to rise significantly, from $263 billion in 2022 to $566 billion
CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction in the Basel Region of Switzerland
CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium,
Unlocking New Insights into Neurodegenerative Diseases: The Essential Role of Complex Cell Models and Live-Cell Analysis
Neurodegenerative diseases, like Alzheimer’s, Parkinson’s, and motor neuron diseases such as Amyotrophic Lateral Sclerosis (ALS) and spinal muscular atrophy, have
Innovative Stem Cell Therapies: Transforming Regenerative Medicine and Patient Care
In recent years, stem cell therapy has emerged as a groundbreaking approach in regenerative medicine, offering patients innovative ways to
Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn
The Purification & Filtration division manufactures filters and membranes for biopharmaceutical and medical technologies, microelectronics, food and beverage goods, and
LINDIS Biotech Partners with Celonic for Production and Commercial Supply of Catumaxomab
LINDIS Biotech has received EMA Marketing Authorisation for catumaxomab, making it the only medicine licensed for the targeted and cancer-directed
Alexion and DHL Partner for 100% Sustainable Aviation Fuel
Dublin, Alexion, AstraZeneca Rare Disease, has partnered with DHL Express to achieve Ireland’s first 100% switch to Sustainable Aviation Fuel